Physician profile
Asher Weisberg
NPI 1033537204
$2,514.91
in general payments reported to CMS, 2019-2025
10 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $80.69 · 2021: $139 · 2022: $11.81 · 2023: $376 · 2024: $446 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377 · Travel and Lodging: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.87 |
| Travel and Lodging | $906.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,118.09 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $254.59 | 2023 | Inspiris Resilia Aortic Valve |
| Atricure, INC. | $225.23 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $181.16 | 2025 | Rotablator Rotational Atherectomy System Console Kit |
| Davol INC. | $156.14 | 2024 | Arista Ah Flexitip |
| Xvivo Perfusion INC. | $137.17 | 2024 | Xvivo Perfusion System (Xps) |
| Abiomed | $129.67 | 2024 | Impella |
| Medistim USA, INC. | $121.78 | 2023 | Miraq |
| Biom'Up France Sas | $110.39 | 2021 | |
| Portola Pharmaceuticals, LLC | $80.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asher Weisberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.